Genfar SA

SHANGHAI – Like most of its peers, Sanofi has placed a large bet on emerging markets, naming it one of seven key platforms to drive top-line growth as the French pharma moves beyond the patent cli

Financings Biopharma financing in the final quarter of 2012 reached $4.2 billion, a 36% increase over Q3’s $3.1 billion, again boosted by a strong showing from follow-on public offerings. The fourth q

In a recurring feature, PharmAsia News combs through quarterly earnings reports to bring you highlights on emerging markets. In part 1, Roche saw in Q3 that a delayed tender in a key emerging ma

IN VITRO DIAGNOSTICS Mergers & Acquisitions ERBA Diagnostics Mannheim GMBH ERBA Diagnostics Inc. Escalon Medical Corp. Drew Scientific Inc. JAS Diagnostics Inc. ERBA Diagnostics Inc. , which is maj